SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-093772
Filing Date
2023-12-06
Accepted
2023-12-06 17:29:17
Documents
12
Period of Report
2023-12-06
Items
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea189644-8k_bimiinter.htm   iXBRL 8-K 26204
  Complete submission text file 0001213900-23-093772.txt   200265

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE bimi-20231206.xsd EX-101.SCH 3009
3 XBRL LABEL FILE bimi-20231206_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE bimi-20231206_pre.xml EX-101.PRE 22355
6 EXTRACTED XBRL INSTANCE DOCUMENT ea189644-8k_bimiinter_htm.xml XML 3411
Mailing Address 725 5TH AVENUE, 15TH FLOOR, 15-01 NEW YORK NY NEW YORK
Business Address 725 5TH AVENUE, 15TH FLOOR, 15-01 NEW YORK NY NEW YORK 212-542-0028
BIMI International Medical Inc. (Filer) CIK: 0001213660 (see all company filings)

IRS No.: 020563302 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34890 | Film No.: 231470577
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries